The in vitro effect of beta- and alpha-IFN on NK activity has been evaluated in 10 patients with Hairy Cell Leukemia (HCL), selected from a larger group on the ground of peripheral blood neoplastic cell infiltration. In 5 patients (group A) more than 85% hairy cells were found, while in the others (group B) a lower infiltration (< 15%) was present. In the first group the baseline NK activity and NK active cells number were undetectable and neither beta- nor alpha-IFN had any enhancing effect. Conversely, in group B patients NK activity was measurable, despite an equally reduced NK active cell amount, only beta-IFN had a statistically significant enhancing effect. We suggest that this discrepancy in NK modulation by beta- and alpha-IFN, in HCL patients, may be ascribed to the differing affinity for type I IFN receptor and/or to postreceptorial activity.
Desanctis, G., Fontana, L., Derossi, G., Bottari, V., Perricone, R., Pasqualetti, D., et al. (1991). Invitro effect of 2 related forms of interferons (beta and alpha) on nk activity of patients with hairy-cell leukemia. EOS, 11(4), 135-139.
Invitro effect of 2 related forms of interferons (beta and alpha) on nk activity of patients with hairy-cell leukemia
FONTANA, LUIGI;PERRICONE, ROBERTO;
1991-01-01
Abstract
The in vitro effect of beta- and alpha-IFN on NK activity has been evaluated in 10 patients with Hairy Cell Leukemia (HCL), selected from a larger group on the ground of peripheral blood neoplastic cell infiltration. In 5 patients (group A) more than 85% hairy cells were found, while in the others (group B) a lower infiltration (< 15%) was present. In the first group the baseline NK activity and NK active cells number were undetectable and neither beta- nor alpha-IFN had any enhancing effect. Conversely, in group B patients NK activity was measurable, despite an equally reduced NK active cell amount, only beta-IFN had a statistically significant enhancing effect. We suggest that this discrepancy in NK modulation by beta- and alpha-IFN, in HCL patients, may be ascribed to the differing affinity for type I IFN receptor and/or to postreceptorial activity.Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons